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Abstract
Background In Germany, performing fertility procedures involving oocyte donation is illegal, as stated by the Embryo 
Protection Law. Nonetheless, in our clinical routine we attend to a steadily rising number of pregnant women, who have 
sought oocyte donation abroad. Due to the legal circumstances many women opt to keep the origin of their pregnancy a 
secret. However, studies have shown, that oocyte donation is an independent risk factor for the development of pregnancy 
complications, such as preeclampsia.
Objective The aim of this study is to evaluate maternal and neonatal outcomes of oocyte donation pregnancies in three large 
obstetric care units in Berlin, Germany.
Methods We retrospectively analyzed all available medical data on oocyte donation pregnancies at Charité University hos-
pital, Vivantes Hospital Friedrichshain, and Neukoelln in the German capital.
Results We included 115 oocyte donation (OD) pregnancies in the present study. Our data are based on 62 singleton, 44 twin, 
7 triplet, and 2 quadruplet oocyte donation pregnancies. According to our data, oocyte donation pregnancies are associated 
with a high risk of adverse maternal and fetal outcome, i.e., hypertension in pregnancy, preterm delivery, Cesarean section 
as mode of delivery, and increased peripartum hemorrhage.
Conclusion Although oocyte donation is prohibited by German law, many couples go abroad to seek reproductive measures 
using oocyte donation after former treatment options have failed. OD pregnancies are associated with a high risk of preec-
lampsia, C-section as mode of delivery, and peripartum hemorrhage. Detailed knowledge of the associated risks is of utmost 
importance to both the patient and the treating physician and midwife.
Keywords Oocyte-donation · Egg-donation · Preeclampsia · Pregnancy risks · Peripartum hemorrhage
Introduction
Since the first successful pregnancy resulting from oocyte 
donation in 1984 [1] was performed, we are witnessing the 
success story of oocyte donation (OD) in the field of repro-
ductive medicine worldwide. The procedure of oocyte dona-
tion encompasses the hormonal stimulation and retrieval of 
stimulated follicles in a usually young and healthy woman, 
who acts as a donor, the insemination with either the part-
ner’s or a donor’s sperm through IVF (in-vitro fertilization) 
or ICSI (intracytoplasmatic sperm injection) and insertion 
of the embryo(s) into the recipient’s uterus.
Formerly used to help women with premature ovar-
ian insufficiency, oocyte donation is nowadays used for a 
number of reasons: inherited diseases, genetic anomalies, 
or peri- or post-menopausal infertility [2]. Infertility is a 
multifactorial disorder that affects 2–3% of the population 
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[3]. In a rapidly changing modern society with a steadily 
increasing life expectancy and long career paths, the issue of 
age-related infertility is aggravated due to the fact that many 
women decide to postpone child-bearing. In 2018 the mean 
age of child-bearing in Germany was 30.0 years; latest data 
suggest that the number in the German population is still ris-
ing [4]. In Germany, around a quarter of women giving birth 
are over the age of 35 years [4, 5]. The number of children 
born by women over the age of 40 years is increasing as 
well, accounting for 43,988 children in 2019 in Germany [4].
According to the European IVF-monitoring Consortium 
73,927 treatment cycles using oocyte donation were per-
formed in 2016, leading to 22,497 deliveries in the partici-
pating countries [6]. The numbers are continuously rising 
according to the European Society of Human Reproduction 
and Embryology [6]. Reproductive procedures involving 
oocyte donation are illegal in Germany due to the Embryo 
Protection Law [7]. Therefore, after prolonged unsuccessful 
cycles of IVF or ICSI in Germany, many couples use oocyte 
donation abroad as their last resort to fulfill their wish to 
have children. Cross-border reproductive care is a growing 
phenomenon, yet little is known about its scope [8].
No data exist on how many German women seek cross-
border reproductive care involving oocyte donation driven 
by legal restrictions in Germany. In our clinical experience 
in some of the largest obstetric care units in Germany, the 
number of pregnancies resulting from oocyte donation in 
Germany rises continuously despite a presumably high num-
ber of unrecorded cases. On account of the legal situation 
in Germany no guidelines or professional recommenda-
tions exist on how to monitor these high-risk pregnancies 
properly. Furthermore, knowledge about the specific risks 
related to oocyte donation pregnancies is scarce. Addition-
ally, affected women might opt to keep the origin of their 
pregnancy a secret for fear of legal implications or discrimi-
nation. This further increases the risk of not being monitored 
appropriately.
So far, no studies concerning oocyte donation pregnan-
cies in Germany have been published. Using a retrospective 
analysis of all available data on oocyte donation pregnancies 
in three large prenatal and obstetric care units in the German 
capital, we aim at assessing the course of pregnancy, mater-
nal, and neonatal outcomes within the exceptional circum-
stances of a country, in which performing oocyte donation 
is illegal.
Methods
Prior to the retrospective analysis formal approval by the 
ethics committee of the Charité University Hospital has been 
sought (number: EA4/176/19).
A retrospective analysis of available data on oocyte preg-
nancies was performed at the departments of obstetrics of 
the Charité University Hospital, Vivantes Hospital Frie-
drichshain, and Vivantes Hospital Neukoelln, all three of 
them being located in Berlin.
In 2019, the Charité University Hospital accounted for 
5526, the Vivantes Hospital Friedrichshain for 3361, and the 
Vivantes Hospital Neukoelln for 3202 live births.
Obstetric data and images were retrieved from birth 
records as well as from Viewpoint obstetric imaging data-
base (GE Healthcare, Solingen, Germany) for further analy-
sis. Medical data at the Charité are stored via the hospital’s 
software system SAP. At the Vivantes Clinics the hospital’s 
software system ORBIS is used to store medical data.
All cases were thoroughly analyzed using all maternal 
and neonatal medical records available. Data analysis at the 
Charité University Hospital includes all medical data col-
lected from the 1st of January 2000 to the 31th of August 
2020, at Vivantes Hospital Friedrichshain from the 1st of 
January 2017 to the 31th of December 2019 and from the 
1st of January 2013 to the 31th of December 2019 at the 
Vivantes Hospital Neukoelln.
All data were analyzed and stored in a pseudonymous 
form. Data analysis was performed using Microsoft Excel, 
version 2016, and G*Power, version 3.1.9.4 [9].
Results
The initial search revealed 141 pregnancies conceived 
through oocyte donation (OD). Over the time period of data 
analysis a steady incline in numbers can be observed. Of 
those, 4 pregnancies were still ongoing and 20 pregnancies 
were excluded due to missing follow-up data. Two pregnan-
cies were excluded from the analysis since they resulted in 
a miscarriage and an ectopic pregnancy. 10 women included 
in our data had at least two OD pregnancies. These were 
counted as individual pregnancies (see Fig. 1). Our study 
collective consists of 62 singleton, 44 twin pregnancies, 7 
triplets, and 2 quadruplets. In total, 115 pregnancies and 179 
fetuses were included in our retrospective analysis.
Patient characteristics
The mean maternal age at pregnancy was 44 years, ranging 
from 29 to 65 years. 68% of women included in the study 
were within the age cohort of 40 to 50. 16% were below the 
age of 40 and 13% above the age of 50. The oldest woman 
included in this study was 65 years old (for patient charac-
teristics see Table 1).
The vast majority of women, 94%, were Caucasian. 4% of 
women were of Asian and 2% of African descent.
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History of prior pregnancies
Fifty percent of pregnant women had not given birth to a 
child prior to the current OD pregnancy. 39% of women 
had given birth once, 8% twice, and 2% at least three times, 
respectively. The vast majority of these previous pregnan-
cies occurred 10–20 years before the current OD pregnancy.
Within our cohort parity ranged between 0 and 13 for-
mer live births. 43% of included women had been pregnant 
at least once, but miscarried. 12.5% had experienced 3 or 
more miscarriages. 8% had at least one ectopic pregnancy. 
In 12% at least one termination of pregnancy had been per-
formed in the past. 4% of women had opted for a termination 
of pregnancy due to severe malformations or chromosomal 
aberrations in the past and 5% of women had given birth to 
a child with genetic disorders, such as trisomy 21 or fragile 
x syndrome. Another 3.5% had previously lost a child within 
the perinatal period.
General medical history
General pre-existing conditions were scarce among the 
recipients and consisted mainly of hypo- or hyperthyroid-
ism (24%). Other pre-existing disorders included ulcerative 
colitis, diabetes, asthma, or depression. Inheritable maternal 
genetic disorders included balanced translocation of chro-
mosomes 1 and 3 as well as fragile x syndrome and were 
rarely present. One woman suffered from a mosaic form of 
Turner syndrome.
Several women had either a known gynecological disor-
der (n: 34) or a medical history of surgery on the ovaries, 
fallopian tubes, uterus, or cervix (n: 53). Gynecological 
disorders consisted mainly of fibroids of the uterus (18%). 
Endometriosis (4%) was rarely reported. 2% of women had 
had an unilateral and 5% a bilateral salpingectomy in the 
past. 13% had a dilatation and curettage in the past, usually 
in the context of an abortion. 14% of women had delivered 
by cesarean section prior to the current pregnancy. 7% of 
women had a conization of the cervix for cervical dysplasia 
in their medical history. A bicornuate uterus was present 
in 2%.
Three percent of patients had experienced cancer treat-
ment in the past, including one case of cervical cancer. 
Among the included patients only one case of premature 
ovarian insufficiency was observed.
Data on current pregnancy
Data on fertility procedures were scarce. In the majority of 
cases oocyte donation and ICSI was performed. At the time 
of oocyte donation, the donor’s average age was 26 years 
(range 18–34, SD 3.45). Three women conceived through 
heterologous insemination in addition to the oocyte dona-
tion. In the majority of cases two embryos were transferred. 
In 23% of pregnancies one embryo was transferred, in 14% 
three embryos, and in 7% four embryos were transferred (for 
data on current pregnancy see Table 2).
The most common destinations for cross-border repro-
ductive tourism in our cohort are Spain and Czech Republic. 
Other countries included Cyprus, Russia, Ukraine, Turkey, 
the United States of America, Iran, Peru, and Ghana. These 
countries were mostly chosen because of a personal or famil-
ial linkage.
The 115 included OD pregnancies comprise 62 singleton 
pregnancies, 44 twin pregnancies, 7 triplet pregnancies, and 
2 quadruplet pregnancy. Two pregnancies were documented 
search result: oocyte-donation 
pregnancies (n=141)
patients with 2 pregnancies (n=9)
patients with 4 pregnancies (n=1)
patients with 1 pregnancy (n=105)







- 1 extrauterine pregnancy
Fig. 1  Flow chart of patients included
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Table 1  Patient characteristics 



















 Of those > 12. weeks of pregnancy 3.5%
Ectopic pregnancy (at least 1) 7%
 Termination of pregnancy
  < 12 weeks of pregnancy (at least 1) 9.5%
  > 12 weeks of pregnancy (at least 1)* 2.6%
 Genetic disorder of the fetus in previous pregnancy (live birth) 5.2%
 Previous termination of pregnancy due togenetic disorder or severe malformations 4.3%
 Previous perinatal death of fetus 3.5%
 Not known 7%













 Laparoscopic removal of ovarian cyst 4.6%
 Resection of the ovary 0.9%
 Prior caesarean section 13.8%






 Mosaic Turner syndrome 0.9%
 Hypothyroidism 19.4%
 Hyperthyroidism 4.6%
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former twin pregnancies with the disappearance of one of 
the fetuses within the first trimester leading to a vanishing 
twin. The group of 44 twin pregnancies consisted of one 
was monochorionic diamniotic pregnancy and 43 dichori-
onic pregnancies.
To enhance comparability, pregnancy outcome data were 
analyzed within the two major groups: singleton (s) (n: 62) 
and dichorionic twin (t) (n: 43) pregnancies. The seven tri-
plet pregnancies and the two quadruplet pregnancies are 
listed separately (see Table 3).
The only monochorionic diamniotic pair of twins in 
our cohort led to a twin-to-twin transfusion syndrome at 
33 weeks of gestation and subsequent cesarean delivery. 
After extensive treatment at the neonatal intensive care unit 
both children were discharged in stable condition.
The group of seven triplet pregnancies consisted of two 
dichorionic triamniotic and five trichorionic pregnancies. 
The two quadruplets were tetrachorionic.
Ultrasound findings
During their pregnancies, all assessed women had detailed I, 
II, and III trimester screening performed by expert maternal 
fetal medicine specialists.
The rate of minor fetal anomalies was low: 10 fetuses, 
5.6%, of pregnancies exhibited minor anomalies detected in 
ultrasound or shortly after birth, including inguinal hernia 
and hydrocele testis.
Pathological findings of the placenta, including bilobed 
placenta (n: 4), placenta previa partialis (n: 6), or totalis (n: 
3) as well as velamentous cord insertion (n: 2) were fre-
quently detected. Another sign of the high rate of placental 
pathology is the high proportion of placental retention (18% 
in singletons, 26% in twins, 29% in triplets and quadruplets). 
Retained placenta was defined as the absence of placental 
expulsion 30 min after delivery of the child.
Pregnancy‑induced hypertensive disorders
Pre-existing hypertension was noted in one singleton 
and one dichorionic twin pregnancy each. Pregnancy-
induced hypertension, a repeatedly measured blood pres-
sure > 140/90 mmHg beginning in the 20th week of preg-
nancy or above, was observed in six singleton, one twin, and 
one triplet pregnancy (see Table 3).
Preeclampsia was defined as pregnancy-induced hyper-
tension plus proteinuria > 300 mg in 24 h urine or > 30 mg/
mmol protein-to-creatinine ratio or other concomitant 
neurological or renal signs. The rate of preeclampsia was 
16% in singleton, 23% in twin, and 22% in triplet or quad-
ruplet pregnancies. Within the preeclamptic group, mean 
SD standard deviation
*All of those due to genetic disorders or severe malformations
Table 1  (continued)
 Previous cancer treatment 2.8%
 Maternal genetic disorder 3.7%






 Systemic lupus erythematosus 0.9%
 Not known 6%
Table 2  Details on current pregnancy (n: 115)
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gestational age at delivery was 35 weeks for singleton and 
34 weeks for dichorionic twin pregnancies. The earliest pre-
mature delivery due to preeclampsia was at 27 weeks in a 
dichorionic twin pregnancy.
In one severe case of preeclampsia in a twin preg-
nancy—after antenatal corticosteroids were applied at 
23 weeks of gestation—emergency cesarean section was 
performed at 26  weeks of gestation after intrauterine 
fetal death of the leading twin. After a prolonged stay 
at the neonatal intensive care unit, the second twin was 
discharged in a reduced, but stable condition with home 
monitoring and home oxygen supplementation.
Hemolysis, elevated liver enzymes, and low platelet 
count (HELLP) syndrome was observed in one singleton 
pregnancy and one twin pregnancy, both were associated 
with severe preeclampsia.
Table 3  pregnancy complications
IUFD spontaneous intrauterine fetal death (> 20 weeks of pregnancy), HELLP Hemolysis elevated liver enzymes low platelet count, SD standard 
deviation
Data on current pregnancy Singleton Twins Triplets/quadruplets
Adverse outcome
 Selective feticide due to multiple pregnancy 0% 0% 44%
 Feticide due to malformations of the fetus 0% 4.5% 0%
 Termination of pregnancy due to severe maternal complications 0% 0% 11.1%
 IUFD 3.2% 9% 11.1%
 Perinatal death due to severe prematurity 3.2% 2.3% 22.2%
 Death due to severe malformations during childhood 1.6% 0% 0%
Hypertension in pregnancy
 Pre-existing hypertension 1.6% 2.3% 0%
 Pregnancy-induced hypertension 9.7% 2.3% 11.1%
 Preeclampsia 16.1% 22.7% 22.2%
 HELLP 1.6% 2.3% 0%









 Premature delivery 34.5% 63.4% 88.9%
  34 + 0 to 37 + 0 13.8% 39% 22.2%
  < 34 + 0 20.7% 24.4% 66.7%
 Antenatal corticosteroids 16.1% 28.6% 44.4%
 Cervical cerclage 8% 4.5% 11.1%
 Pessary 1.6% 2.3% 33.3%
 Progesterone 1.6% 4.5% 11.1%
 Perinatal death due to severe prematurity 1.6% 4.5% 22.2%
Mode of delivery (live births)
 Vaginal delivery 8.1% 9.3% 0%
 Vacuum extraction delivery 4.8% 2.3% 0%
 Caesarean section 83.9% 88.4% 100%
  Planned 35.5% 20.9% 0%
  Unplanned or emergency 49% 67.4% 100%
Stillbirth 3.2% 2.3% 33.3%









 > 500 ml blood loss 25% 29% 28.6%
 > 1500 ml blood loss 9% 12.9% 28.6%
 Total > 500 ml blood loss 34% 41.9% 57.2%
 Placental retention > 24 SSW 18.2% 25.8% 28.6%
 Placental abruption 0% 3.2% 0%
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Prematurity
In eight patients premature contractions lead to premature 
cervical ripening and preterm delivery. Premature rupture 
of the membrane was frequently found as well (n: 16). 
Mean age at delivery was 37, 35, and 28 weeks of gesta-
tion for singleton pregnancies, dichorionic twin pregnan-
cies, and the group of triplets and quadruplets (see Table 3). 
Within our cohort, 21% of singletons, 24% of twins, and 
67% of triplets or quadruplets were delivered before the 
34th week of gestation was completed. In total, premature 
delivery < 37 + 0 weeks of gestation accounted for 35% of 
singleton, 63% of dichorionic twin, and 89% of triplet/quad-
ruplet pregnancies.
Sixteen percent of singletons, 29% of twins, and 44% of 
triplets or quadruplets received antenatal corticosteroids 
(12 mg of dexamethasone twice within 24 h) as well as 
tocolysis for 48 h, usually with nifedipine orally. Surgical 
cerclage of the cervix, pessary therapy, or medication with 
progesterone were commonly applied to impede premature 
delivery (8%, 2%, and 2%, respectively, in singletons; 5%, 
2%, and 5%, respectively, in twins; 11%, 33%, and 11%, 
respectively, in triplets or quadruplets).
Adverse outcomes
Spontaneous intrauterine fetal death (IUFD) of one fetus 
occurred in two singleton, four twin, and one triplet pregnan-
cies (singleton: 3.2%, twin: 9%, triplets/quadruplets: 11.1%).
In addition, five perinatal deaths occurred due to severe 
prematurity (singleton: 3.2%, twin: 2.3%, triplets/quadru-
plets: 22.2%). In four of these pregnancies age at delivery 
was between 21 and 23 weeks of gestation causing imme-
diate fetal demise. In case of the singleton pregnancy, the 
neonate was born at 26 weeks of gestation and died three 
weeks after birth despite intensive care measures.
In six pregnancies feticides were performed, in two of 
those due to malformations of the fetus, including micro-
duplication15q11q13 syndrome (twins: 4.5%, triplets/
quadruplets: 44%). The remaining four pregnancies were 
three triplet pregnancies and one quadruplet pregnancy. In 
three of the trichorionic triplet pregnancies multifetal preg-
nancy reduction of one fetus was performed. One led to the 
delivery of two healthy children at 37 weeks of gestation. 
Another one resulted in stillbirth at 23 weeks of gestation. 
The other pregnancy was terminated at 17 weeks of gesta-
tion—2 weeks after multifetal pregnancy reduction had been 
performed—due to severe maternal complications through 
massive loss of weight, hyperemesis, esophagitis, and preg-
nancy-induced hyperthyroidism. In this case, stillbirth was 
followed by massive peripartum hemorrhage with 2.5 l of 
blood loss requiring blood and plasma transfusions.
IUFD occurred in another trichorionic triplet pregnancy, 
two healthy children were delivered at 35 weeks of gestation.
One dichorionic triamniotic triplet pregnancy resulted in 
preeclampsia and the delivery of three healthy neonates at 
36 weeks of gestation.
The remaining two triplet pregnancies, one trichorionic, 
and one dichorionic triamniotic pregnancy resulted in pre-
mature delivery at 27 and 29 weeks, respectively, with good 
neonatal outcome.
In one quadruplet pregnancy selective feticide of two 
fetuses was performed in the 12th week of pregnancy. In this 
case, selective feticide was requested by the patient on the 
grounds of the high pregnancy risks associated with multi-
fetal pregnancy. At 23 weeks of gestation premature rupture 
of the membranes led to chorioamnionitis and subsequent 
perinatal death of all fetuses.
The other quadruplet pregnancy was affected by severe 
preeclampsia in 26 weeks of gestation and subsequent C-sec-
tion. All four neonates survived although all of them were 
affected by common preterm complications. One neonate 
was afflicted by necrotizing enterocolitis and consecutive 
bowel perforation leading to emergency surgery on the 7th 
day of life. Another neonate suffered from intraventricular 
hemorrhage on the 3th day of life. He was treated by the 
surgical implantation of a ventriculoperitoneal shunt sys-
tem. Today, the 5-year-old boy shows neurological long-
term damage, such as hemiparesis and spasticity, due to pos-
themorrhagic hydrocephalus. The other two boys suffered 
from sepsis, but were both treated successfully at the neonate 
intensive care unit.
Overall outcome of the seven triplet pregnancies and 
the two quadruplet pregnancy was poor; out of 29 only 18 
fetuses survived (including feticides) (see Table 3).
Delivery
The majority of pregnancies were delivered by cesarean sec-
tion (singleton: 83.9%, twins: 88.4%, triplets/quadruplets: 
100%) with a large percentage of unplanned of emergency 
C-sections (singleton: 49%, twins: 67.4%, triplets/quadru-
plets: 100%; Table 3). Reasons for planned cesarean section 
were as follows: Uterine scars due to prior operations, mul-
tiple pregnancies, or breech position of the fetus. Unplanned 
cesarean sections were performed for the following reasons: 
premature contractions or rupture of the membrane, patho-
logical fetal heart tracing indicating major fetal distress, pro-
longed or obstructed labor, fetal malposition or malpresenta-
tion, IUFD of one fetus in multifetal pregnancies, premature 
placental abruption, or severe bleeding during childbirth. 
Four children were delivered using vacuum extraction due 
to major fetal distress.
3.2% of singleton, 4.5% of twin, and 33.3% of triplet or 
quadruplet deliveries were stillbirths.
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Peripartum hemorrhage
Retention of the placenta leading to the manual removal of 
the placenta occurred in 18% of singleton, 26% of twin, and 
29% of triplet or quadruplet deliveries (see Table 3).
Increased peripartum blood loss occurred irrespective of 
multiplicity of the pregnancy. Mean blood loss was 683 ml 
in singletons (range 200–3000 ml), 782 ml in dichorionic 
twins (range 300–3000 ml), and 1214 ml in triplets or quad-
ruplets (range 400–2500 ml).
In 39% of pregnancies estimated blood loss was more 
than 500 ml during delivery. In 9% of singleton, 13% of 
twin, and 29% of triplet/quadruplet pregnancies peripartum, 
blood loss was more than 1.5 l necessitating manual tech-
niques, intensified treatment with uterotonic agents, applica-
tion of tranexamic acid, and/or transfusion of erythrocytes 
and plasma.
The maximum peripartum blood loss was three liters and 
occurred in three cases, both in singleton and twin preg-
nancies. In three cases hemorrhage was so massive that the 
attending physicians opted for the application of a Bakri 
balloon and/or tamponade or surgical ligation of the uterine 
artery. In none of these cases hysterectomy was needed.
Neonatal outcome
There was a high rate of adverse pregnancy outcomes, espe-
cially affecting triplets and the quadruplet pregnancy (see 
Table 4 for neonatal outcome).
Mean weight at birth was 2803 g in singleton and 2266 g 
in twin pregnancies. In 11% of singleton and 19% of twin 
pregnancies birth weight was below the 10th percentile and 
8% or 2%, respectively, were above the 90th percentile.
APGAR values below 7 at 5 and 10  min after birth 
occurred rarely and most neonates adapted quickly (single-
ton: 6.4%, twins: 10.6%).
The vast majority of neonates presented with a pH of the 
umbilical cord artery within the normal ranges above 7.2 
(93% of singletons, 89% of twins).
Discussion
In our cohort, patients using cross-border fertility treatment 
involving oocyte donation were on average 44 years old and 
had a history of at least one miscarriage, ectopic pregnancy, 
or termination of pregnancy. 13% of assessed women were 
above the age of 50. The oldest woman included in the cur-
rent study was 65 years old. A Spanish study found sig-
nificant differences between German, French, and Italian 
couples seeking cross-border reproductive care involving 
oocyte donation [10]. In comparison to French and Italian 
women, most German women had already undergone more 
than three unsuccessful IVF or ICSI cycles [10, 11] and were 
older than couples from France or Italy. Comparing our data 
to the literature, mean age at pregnancy within our cohort 
of patients seems to be higher than in Spanish, Italian, or 
French women undergoing oocyte donation (38–41 years) 
[10]. Although studies have revealed that oocyte donation 
is an independent risk factor for pregnancy complications 
[12], age-related implications might contribute to the high 
number of complications within our study population [13].
Half of the women had given birth to at least one child, 
usually 10–20 years before, and chose to have another child 
over the age of 40. Judging from the available data, genetic 
disorders, premature ovarian insufficiency, or previous can-
cer treatment are rare. Instead, age-related infertility was the 
main reason for the use of oocyte donation.
As a result of age-related risks, but also moral implica-
tions, several countries have opted to implement an upper 
age limit to financial reimbursement of fertility procedures, 
for example, until the age of 43 in France [2, 13].
In 56% of pregnancies two embryos from an—on aver-
age—26 years old donor were transferred into the recipi-
ent’s uterus. As a result, multiple pregnancies after oocyte 
donation are rather the rule than the exception. In 14% three 
embryos and in 7% of patients four embryos were transferred 
resulting in seven triplets and one quadruplet pregnancies. 
The vast majority used the partner’s sperm for fertilization. 
Heterologous insemination has been rarely used. It is note-
worthy that studies have shown that sperm from an unfamil-
iar donor increases the risk of preeclampsia further [14, 15].
Triplet and quadruplet pregnancies are burdened with a 
particularly high risk of adverse maternal and/or fetal out-
come. After returning from abroad half of these women 
opted for multifetal pregnancy reduction of one or two 
fetuses to reduce the risks associated with triplet or quadru-
plet pregnancies. Thus, detailed counseling about potential 
risks of multifetal pregnancies is highly recommended prior 
to the insertion of several donated oocytes. As shown above, 
selective feticide is associated with a high risk of fetal death 
of another fetus or late miscarriage of the pregnancy. Of 
29 fetuses included in the group of triplet and quadruplet 
pregnancies only 18 fetuses survived. In the literature, out-
come data on triplet or even quadruplet OD pregnancies are 
scarce. Only few case series have been published, indicating 
that obstetric complications, including preeclampsia, gesta-
tional diabetes, and preterm delivery, are high [16]. Selec-
tive feticide is commonly performed in triplets or quadruplet 
pregnancies [16].
Since the turn of the century, a change of strategies has 
taken place in reproductive medicine away from a transfer 
of many embryos—guaranteeing a high rate of pregnancies 
with consecutive collateral damage—toward a transfer of 
only one or two well-developed blastocysts—a lower rate 
of, but healthy, pregnancies [6]. In a few countries, however, 
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including Bosnia-Herzegovina, Lithuania, and Serbia, more 
than 40% of transfers are still performed using three embryos 
[6]. As a consequence of the per se increased risks of OD 
pregnancies a single-embryo transfer should be preferred.
In the current study, the rate of pregnancy-induced hyper-
tension, preeclampsia and HELLP syndrome, was 10–30%. 
The rate of preeclampsia was 16% in singleton, 23% in 
dichorionic twin, and 22% in triplet or quadruplet pregnan-
cies. The data on triplet and quadruplet pregnancies ought 
to be interpreted with caution since mean time of delivery 
was only 28 weeks of gestation.
Preeclampsia frequently led to premature delivery. In 
women affected by preeclampsia, mean gestational age was 
35 weeks for singleton and 33 weeks for dichorionic twins. 
HELLP syndrome was observed in one singleton pregnancy 
and one twin pregnancy, both were associated with severe 
preeclampsia.
Our data are consistent with a meta-analysis conducted 
by Storgaard et al. in 2016 that took into account 35 studies 
[12]. Results showed a significantly increased risk of hyper-
tensive disorders and preeclampsia, premature birth, low 
birth weight, abnormal blood loss during child-birth, and a 
higher number of planned or emergency cesarean sections 
in oocyte donation pregnancies compared to IVF or ICSI 
pregnancies or pregnancies conceived through natural con-
ception [12]. The data were adjusted for confounders, such 
as singleton versus multiple pregnancies and maternal age. 
The incidence of preeclampsia in singleton oocyte dona-
tion pregnancies ranged from 9.3 to 16.9% as opposed to 
3.2–11.5% in IVF/ICSI and 2.4–3.8% in natural conception 
pregnancies. Considering twin pregnancies preeclampsia 
was present in 15.8–45.8% in oocyte donation pregnancies 
in contrast to 7.4–13.0% in IVF/ICSI pregnancies and 7.1% 
in naturally conceived pregnancies. Storgaard et al. calcu-
lated a two- or three-fold higher risk for the development 
of preeclampsia in singleton or multiple oocyte donation 
pregnancies than in natural conception pregnancies [12]. In 
developed countries hypertensive pregnancy disorders cause 
16% of all maternal deaths peripartum and 25% of perinatal 
deaths [17]. Additionally, preeclampsia increases the risk 
of cardiovascular disorders later in life for both mother and 
child [18].
Several studies conducted on OD pregnancies support 
the hypothesis that abnormal placentation is induced by 
the immunological reaction of the mother to the genetically 
unknown fetus [19], a complete allograft.
Premature delivery was common with a mean gestational 
age at delivery of 37, 35, and 28 weeks of gestation for sin-
gleton, dichorionic twins, and triplet/quadruplet pregnancy. 
Interventions, including antenatal corticosteroids, tocolysis 
for 48 h, surgical cerclage of the cervix, pessary, or pro-
gesterone, were used in several cases. In total, premature 
delivery < 37 + 0 weeks of gestation accounted for 35% of 
singleton, 63% of dichorionic twin, and 89% of triplet/quad-
ruplet pregnancies. 22% of triplet or quadruplet pregnancies 
resulted in perinatal death due to severe prematurity.
The majority of children were delivered by cesarean sec-
tion. The high rate of C-sections has been described before 
[12]. In our clinical experience, women who have undergone 
oocyte donation to achieve pregnancy have a maximum need 
for security and therefore frequently opt for a planned C-sec-
tion. However, our data show that the number of emergency 
C-sections exceeds the number of planned C-sections by far.
As shown above, the rate of peripartum hemorrhage with 
a blood loss > 500 ml was high. Severe hemorrhage with 
more than 1.5 l occurred in 9–29% of deliveries necessitat-
ing intensified measures. Severe blood loss is closely linked 
with placental pathology and uterine atony. Therefore, the 
high rate of placental retention is not surprising. Serena et al. 
detected a percentage of peripartum hemorrhage similar to 
ours, of 22% [20].
The above published data show a high percentage of 
adverse outcomes, such as IUFD accounting for 3.2% of 
singleton, 9% of twin, and 11.1% of triplet or quadruplet 
pregnancies. Perinatal death due to severe prematurity was 
as high as 22% of triplet or quadruplet pregnancies.
Within the group of singletons and dichorionic twins 
birth weight below the 10 percentile was seen in 11% and 
18%, respectively. Several meta-analysis published on peri-
natal outcome in OD pregnancies show a significantly higher 
risk of low or very low birth weight, intrauterine growth 
retardation, preterm birth, and longer hospitalization of the 
neonate [21, 22].
A possible factor influencing birth weight might be the 
fertility procedure used. For most pregnancies, data on the 
exact fertility method used were not available. Studies have 
shown that frozen embryos result in a statistically higher 
birth weight than fresh embryos [23].
In light of the prohibition of oocyte donation in Germany 
a proportion of the German population chooses to go abroad 
to have fertility procedures involving donated oocytes per-
formed. How and under which regulations these procedures 
are performed is out of our reach, but the German health care 
system still has to shoulder the potential burden associated 
with it.
Health care personnel in Germany should be aware of 
the rising number of OD pregnancies and ask their patients 
about the nature of their pregnancy after assuring them of 
their professional confidentiality. Taking into account the 
significantly increased risks of pregnancy-induced hyper-
tension, preeclampsia, preterm delivery, severe peripartum 
hemorrhage, and placental pathology, we recommend in-
depth care and monitoring of these high-risk pregnancies. 
Patients should be counseled about these risks and learn 
to recognize early signs of preeclampsia. Treating doctors 
and midwives should be alert for signs and symptoms of 
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preeclampsia. According to FMF guidelines mothers at risk 
for preeclampsia should receive cardiovascular screening 
and prophylactic medication with acetylsalicylic acid [24]. 
Delivery should take place at a tertiary care hospital with 
an interdisciplinary team of health care professionals avail-
able at all times as well as a neonatal intensive care unit. 
Close attention should be paid to the blood loss during deliv-
ery. Obstetric care personnel should be ready to intervene 
as early as possible with all necessary measures to impede 
unnecessary additional hemorrhage.
Strengths and limitations of this study
This paper represents the first analysis of oocyte donation 
pregnancies in Germany. It shows considerable risks associ-
ated with oocyte donation pregnancies and emphasizes the 
importance to train health care personnel properly. Due to 
the exceptional circumstances regarding the legal situation 
of oocyte donation pregnancies in Germany, we hypothesize 
that the above-mentioned number of OD pregnancies is only 
the tip of the iceberg. We assume that a number of women do 
not disclose information about the origin of their pregnancy 
due to fear of legal persecution or prejudices. Another factor 
might be that women who have received donated oocytes are 
not aware of the significantly increased pregnancy risks and 
therefore do not see the necessity of disclosing information 
on the origin of their pregnancy. On the other hand, since 
knowledge about oocyte donation is limited, medical person-
nel might not specifically ask about the mode of concep-
tion. Finally, diagnostic codes for “oocyte donation” do not 
exist in Germany, which impedes data analysis significantly. 
Therefore, the prevalence of OD pregnancies in Germany 
cannot be extracted from our data due to the presumably 
high number of unrecorded cases.
In view of the rapidly changing demographic situation in 
Germany these high-risk pregnancies will play an even more 
important role in the future.
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